Transcripts Invivyd, Inc.

Equities

IVVD

US00534A1025

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
1.84 ^USD	+1.66%		-4.66%	-53.30%

May. 31	Invivyd in General Alignment With FDA on Emergency Use Authorization Pathway for Monoclonal Covid Antibodies	MT
May. 31	Invivyd Announces General Alignment with U.S. FDA on A Repeatable, Expedient Emergency Use Authorization Pathway for the Prevention and Treatment of Symptomatic COVID-19, Based on Compact Clinical Programs to Establish Safety and Immunobridging for Serial Monoclonal Antibodies	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Invivyd, Inc., Q1 2024 Earnings Call, May 09, 2024	May. 09
Transcript : Invivyd, Inc. - Special Call	Apr. 04
Transcript : Invivyd, Inc. - Special Call	Mar. 22
Transcript : Invivyd, Inc., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
Transcript : Invivyd, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-13-2023 12:55 PM	23-09-13
Transcript : Invivyd, Inc., Q2 2023 Earnings Call, Aug 10, 2023	23-08-10
Transcript : Invivyd, Inc. Presents at Jefferies 2023 Global Healthcare Conference, Jun-09-2023 11:30 AM	23-06-09
Transcript : Invivyd, Inc., Q1 2023 Earnings Call, May 11, 2023	23-05-11
Transcript : Invivyd, Inc. Presents at H.C. Wainwright BioConnect Investor Conference at Nasdaq 2023, May-02-2023 04:00 PM	23-05-02
Transcript : Invivyd, Inc., 2022 Earnings Call, Mar 23, 2023	23-03-23
Transcript : Invivyd, Inc., Q3 2022 Earnings Call, Nov 10, 2022	22-11-10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer